eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank

4/2018
vol. 43
 
Share:
Share:
more
 
 
abstract:
Review paper

Natural antibodies – facts known and unknown

Joanna Palma, Beata Tokarz-Deptuła, Jakub Deptuła, Wiesław Deptuła

(Centr Eur J Immunol 2018; 43 (4): 466-475)
Online publish date: 2018/12/31
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
In contrast to adaptive antibodies, natural antibodies are present in a non-immunised organism from birth, and they do not include anti-Gal antibodies and/or anti-Gal natural antibodies, which are developed as a result of the effect of the -Gal epitope and physiological flora. Natural antibodies are the first line of the organism’s defence before the formation of the immunity created via the stimulation of elements that determine specific and non-specific immunity. This is especially important in the case of infants. Despite the fact that natural antibodies differ in their function from adaptive antibodies, they are polyreactive and they detect autoantigens and new antigenic determinants. Natural antibodies are formed from the subpopulation of B lymphocytes, mainly B1 lymphocytes and B lymphocytes of the marginal zone. This phenomenon is supported by the fact that when the quantity of these cells in the organism decreases, which happens with age, the level of natural antibodies also decreases and the risk of illnesses of old age becomes higher. During ontogenesis, these antibodies participate in many physiological processes, including the “support” of the immune system and homeostasis, the prevention of inflammation, infections and other pathological states, such as autoimmune and cardiovascular diseases, or the process of carcinogenesis. The best known natural antibody is IgM, but the role of IgGs and IgAs is also considered important. Nowadays, many researchers also mention intravenous immunoglobulins, which are used in the treatment of numerous illnesses, and there are discussions on the possibility of increasing their potential if they were based on natural antibodies.
keywords:

immunology, antibodies, natural antibodies, B1 lymphocytes, immunoglobulin

references:
Born WK, Huang Y, Zeng W, et al. (2016): A special connection between  T cells and natural antibodies? Arch Immunol Ther Exp 64: 455-462.
Chen Y, Khanna S, Goodyear CS, et al. (2009): Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J Immunol 183: 1346-1359.
Chen Y, Park YB, Patel E, Silverman GJ (2009): IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J Immunol 182: 6031-6043.
Deptuła W, Tokarz-Deptuła B, Stosik M (2013): Immunologia dla biologów. Wyd. Nauk. US, Szczecin.
Grönwall C, Akhter E, Oh C, et al. (2012): IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE. Clin Immunol 142: 390-398.
Merbl Y, Zucker-Toledano M, Quintana FJ, Cohen IR (2007): Newborn humans manifest autoantibodies to defined self-molecules detected by antigen microarray informatics. J Clin Invest 117: 712-718.
Panda S, Ding JL (2015): Natural antibodies bridge innate and adaptive immunity. J Immunol 194: 13-20.
Rothstein TL (2016): Natural antibodies as rheostats for susceptibility to chronic diseases in the aged. Front Immunol 7: 127.
Silverman GJ (2015): Protective natural autoantibodies to apoptotic cells: evidence of convergent selection of recurrent innate-like clones. Ann N Y Acad Sci 1362: 164-175.
Ugorski M (1979): Naturalne przeciwciała. Post Hig Med Dośw 33: 239-248.
Holodick NE, Rodríguez-Zhurbenko N, Hernández AM (2017): Defining Natural Antibodies. Front Immunol 8: 872.
Grönwall C, Silverman GJ (2014): Natural IgM: Beneficial autoantibodies for the control of inflammatory and autoimmune disease? J Clin Immunol 34 (Suppl 1): 12-21.
Boyden S (1963): Cellular recognition of foreign matter. Int Rev Exp Pathol 2: 311-356.
Rothstein TL, Griffin DO, Holodick NE, et al. (2013): Human B-1 cells take the stage. Ann N Y Acad Sci 1285: 97-114.
Avrameas S, Selmi C (2013): Natural autoantibodies in the physiology and pathophysiology of the immune system. J Autoimmun 41: 46-49.
Lobo PI (2016): Role of natural autoantibodies and natural IgM anti-leucocyte autoantibodies in health and disease. Front Immunol 7: 198.
Panda S, Zhang J, Tan NS, et al. (2013): Natural IgG antibodies provide innate protection against ficolin-opsonized bacteria. EMBO J 32: 2905-2919.
Avrameas SC (2016): Autopolyreactivity confers a holistic role in the immune system. Scand J Immunol 83: 227-234.
Baumgarth N (2016): B-1 cell heterogeneity and the regulation of natural and antigen-induced IgM production. Front Immunol 7: 1-9.
Durand CA, Hartvigsen K, Fogelstrand L, et al. (2009): Phosphoinositide 3-kinase p110 delta regulates natural antibody production, marginal zone and B-1 B cell function, and autoantibody responses. J Immunol 183: 5673-5684.
Savage HP, Baumgarth N (2015): Characteristics of natural antibodysecreting cells. Ann N Y Acad Sci 1362: 132-142.
Galili U (2013): Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits. Immunology 140: 1-11.
Huai G, Qi P, Yang H, Wang Y (2016): Characteristics of -Gal epitope, anti-Gal antibody, 1,3 galactosyltransferase and its clinical exploitation. Int J Mol Med 37: 11-20.
Kralickova P, Kuhnova J, Soucek O, et al. (2017): Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies. J Immol Reserch 2017: 1-8.
Xu X, Ng SM, Hassouna E, et al. (2015): Human-derived natural antibodies: biomarkers and potential therapeutics. Future Neurol 10: 25-39.
Britschgi M, Olin CE, Johns HT, et al. (2009): Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer’s disease. Proc Natl Acad Sci USA 106: 12145-12150.
Nicoletti C, Yang X, Cerny J (1993): Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosporylocholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumonia. J Immunol 150: 543-549.
Bachi AL, Suguri VM, Ramos LR, et al. (2013): Increased production of autoantibodies and specific antibodies in response to influenza virus vaccination in physicallu active older individuals. Results Immunol 3: 10-16.
Lacroix-Desmazes S, Mouthon L, Kaveri SV, Kazatchkine MD (1995): Analysis of the natural human IgG antibody repertoire: life-long stability of reactive towards self-antigens contracts with age-dependent diversification of reactivities against bacterial antigens. Eur J Immunol 25: 598-604.
Lacroix-Desmazes S, Mouthon L, Kaveri SV, et al. (1999): Stability of natural self-reactive antibody repertoires during aging. J Clin Immunol 19: 26-34.
Nagele EP, Acharya NK, DeMarshall C, et al. (2013): Natural IgG autoantibodies are abundant and ubiquitous in human sera and their number is influenced by age, gender, and disease. PLoS ONE 8: e60726.
Chapman CJ, Murray A, McElveen JE, et al. (2008): Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax 63: 228-233.
Hernández AM, Toledo D, Martinez D, et al. (2008): Characterization of the antibody response against NeuGcGM3 ganglioside elicited in non-small cell lung cancer patients immunised with an anti-idiotype antibody. J Immunol 181: 6625-6634.
Kyaw T, Tay C, Krishnamurthi S, et al. (2011): B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ Res 109: 830-840.
Madi A, Bransburg-Zabary S, Kenett DY, et al. (2012): The natural autoantibody repertoire in newborns and adults: a current overview. Adv Exp Med Biol 750: 198-212.
Madi A, Hecht I, Bransburg-Zabary S, et al. (2009): Organization of the autoantibody repertoire in healthy newborns and adults revealed by system level informatics of antigen microarray data. Proc Natl Acad Sci USA 106: 14484-14489.
Padilla ND, Ciurana C, van Oers J, et al. (2004): Levels of natural IgM antibodies against phosphorylcholine in healthy individuals and in patients undergoing isolated limb perfusion. J Immunol Methods 293: 1-11.
Ravandi A, Boekhold SM, Mallat Z, et al. (2011): Relationship of IgG and IgM autoantibodies and immune complex to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study. J Lipid Res 52: 1829-1836.
Szabo P, Relkin N, Wekselr ME (2008): Natural human antibodies to amyloid beta peptide. Autoimmmun Rev 7: 415-420.
Tsimikas S, Brilakis ES, Lennon RJ, et al. (2007): Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery and cardiovascular events. J Lipid Res 48: 425-433.
Vas J, Gronwall C, Silverman GJ (2013): Fundamental roles of the innate-like repertoire of natural antibodies in immune homeostasis. Front Immunol 4: 4.
Bos NA, Kimura H, Meewsen CG, et al. (1989): Serum immunoglobulin levels and naturally occurring antibodies against carbohydrate antigens in germ-free BALB/c mice fed chemically defined ultrafiltrated diet. Eur J Immunol 19: 2335-2339.
Cohen IR, Young DB (1991): Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today 12: 105-110.
Malinowska M, Tokarz-Deptuła B, Deptuła W (2017): Mikrobiom człowieka. Post Mikro 56: 129-138.
Shulzhenko N, Morgun A, Hsiao W, et al. (2011): Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat Med 17: 1585-1593.
Stoel M, Jiang HQ, van Diemen CC, et al. (2005): Restricted IgA repertoire in both B-1 and B-2 cell-derived gut plasmablasts. J Immunol 174: 1046-1054.
Huang Y, Heiser RA, Detanico TO, et al. (2015):  T cells affect IL-4 production and B-cell tolerance. Proc Natl Acad Sci USA 11: 39-48.
Stäger S, Alexander J, Kirby AC (2003): Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses. Nat Med 9: 1287-1292.
Montecino-Rodriguez E, Dorshkind K (2012): B-1 B cell development in the fetus and adult. Immunity 36: 13-21.
Griffin DO, Holodick NE, Rothstein TL (2011): Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70. J Exp Med 208: 67-80.
Griffin DO, Rothstein TL (2012): Human b1 cell frequency: isolation and analysis of human b1 cells. Front Immunol 3: 122.
Griffin DO, Rothstein TL (2012): Human “orchestrator” CD11b(+) B1 cells spontaneously secrete interleukin-10 and regulate T-cell activity. Mol Med 18: 1003-1008.
Hayakawa K, Hardy RR, Parks DR, Herzenberg LA (1983): The Ly-1 B cell subpopulation in normal immunodefective and autoimmune mice. J Exp Med 157: 202-218.
Hayakawa K, Hardy RR, Herzenberg LA (1986): Peritoneal Ly-1 B cells: genetic control, autoantibody production, increased lambda light chain expression. Eur J Immunol 16: 450-456.
Shao W, Hu F, Ma J, et al. (2016): Epithelial cells are a source of natural IgM that contribute to innate immune response. Int J Biochem Cell Biol 73: 19-29.
Baccala R, Quang TV, Gilbert M, et al. (1989): Two murine natural polyreactive autoantibodies are encoded by nonmutated germ-line genes. Proc Natl Acad Sci USA 86: 4624-4628.
Hartman AB, Mallett CP, Srinivasappa J, et al. (1989): Organ reactive autoantibodies from non-immunised adult BALB/c mice are polyreactive and express non-biased VH gene usage. Mol Immunol 26: 359-370.
Choi YS, Dieter JA, Rothaeusler K, et al. (2012): B-1 cells in the bone marrow are a significant source of natural IgM. Eur J Immunol 42: 120-129.
Holodick NE, Tumang JR, Rothstein TL (2012): Immunoglobulin secretion by B1 cells: differential intensity and IRF4-dependence of spontaneous IgM secretion by peritoneal and splenic B1 cells. Eur J Immunol 40: 3007-3016.
Chen ZJ, Wheeler CJ, Shi W, et al. (1998): Polyreactive antigen-binding B cells are the predominant cell type in the newborn B cell repertoire. Eur J Immunol 28: 989-994.
Briles DE, Forman C, Hudak S, Claflin JL (1982): Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J Exp Med 156: 1177-1185.
Briles DE, Nahm M, Schroer K, et al. (1981): Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae. J Exp Med 153: 694-705.
Caidahl K, Hartford M, Karlsson T, et al. (2013): IgM-phosphorylcholine autoantibodies and outcome in acute coronary syndromes. Int J Cardiol 167: 464-469.
Grönwall C, Chen Y, Vas J, et al. (2012): MAPK phosphatase-1 is required for regulatory natural autoantibody-mediated inhibition of TLR responses. Proc Natl Acad Sci USA 109: 19745-19750.
Shaw PX, Goodyear CS, Chang MK, et al. (2003): The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells. J Immunol 170: 6151-6157.
Hardy RR, Carmack CE, Shinton SS, et al. (1989): A single VH gene is utilized predominantly in anti-BrMRBC hybridomas derived from purified Ly-1 B cells. Definition of the VH11 family. J Immunol 142: 3643-3651.
Gray M, Miles K, Salter D, et al. (2007): Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci USA 104: 14080-14085.
Rodriguez-Zhurbenko N, Martinez D, Blanco R, et al. (2013): Human antibodies reactive to NeuGcGM3 ganglioside have cytotoxic anti-tumor properties. Eur J Immunol 43: 826-837.
Hernández AM, Rodriguez N, Gonzalez JE, et al. (2011): Anti-NeuGcGM3 antibodies, actively elicited by idiotypic vaccination in nonsmall cell lung cancer patients, induce tumor cell death by an oncosis-like mechanism. J Immunol 186: 3735-3744.
Ulsemer P, Henderson G, Toutounian K, et al. (2013): Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6. Cancer Immunol. Immunother 62: 875-887.
Boffey J, Nicholl D, Wagner ER, et al. (2004): Innate murine B cells produce anti-disialosyl antibodies reactive with Campylobacter jejuni LPS and gangliosides that are polyreactive and encoded by a restricted set of unmutated V genes. J Neuroimmunol 152: 98-111.
Kayed R, Jackson GR, Estes DM, Barrett AD (2011): Alzheimer’s disease: review of emerging treatment role for intravenous immunoglobulins. J Cent Nerv Sys Dis 3: 67-73.
Coutinho A, Kazatchkine MD, Avrameas S (1995): Natural autoantibodies. Curr Opin Immunol 7: 812-818.
Ehrenstein MR, Notley CA (2010): The importance of natural IgM: scavenger, protector and regulator. Nat Rev Immunol 10: 778-786.
McCoy KD, Harris NL, Diener P, et al. (2006): Natural IgE production in the absence of MHC class II cognate help. Immunity 24: 329-339.
Panda S, Zhang J, Yang L, et al. (2014): Molecular interaction between natural IgG and ficolin-mechanistic insights on adaptive-innate immune crosstalk. Sci Rep 4: 3675.
Rahyab AS, Alam A, Kapoor A, Zhang M (2011): Natural antibody – biochemistry and functions. Glob J Biochem 2: 283-288.
Schwartz-Albiez R, Monteiro RC, Rodriguez M, et al. (2009): Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation. Clin Exp Immunol 158: 43-50.
Bayry J, Negi VS, Kaveri SV (2011): Intravenous immunoglobulin therapy in rheumatic diseases. Nat Rev Rheumatol 7: 349-359.
Adamiak D, Tokarz-Deptuła B, Deptuła W (2013): Sekrecyjna immunoglobulina klasy M (SIgM). Kosmos 62: 507-512.
Wang H, Coligan JE, Morse HC (2016): Emerging functions of natural IgM and its Fc receptors FCMR in immune homeostasis. Front Immunol 7: 99.
Boes M, Prodeus AP, Schmidt T, et al. (1998): A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 188: 2381-2386.
Tsiantoulas D, Gruber S, Binder CJ (2013): B-1 cell immunoglobulin directed against oxidation-specific epitopes. Front Immunol 3: 415.
Bonagura VR, Mendez L, Agostino N, Pernis B (1987): Monomeric (7S) IgM found in the serum of rheumatoid arthritis patients share idiotypes with pentameric (19S) monoclonal rheumatoid factors. J Clin Invest 79: 813-818.
Fakunle YM, Aranguibel F, de Villiers D, et al. (1979): Monomeric (7S) IgM in chronic liver disease. Clin Exp Immunol 38: 204-210.
Vire B, David A, Wiestner A (2011): TOSO, the FcµR is highly expressed on chronic lymphocytic leukemia B cells, internalizes opun IgM binding shuttles to the lysosome, and is downregulated in response to TLR activation. J Immunol 187: 4040-4050.
Notley CA, Brown MA, Wright GP, Ehrenstein MR (2011): Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells. J Immunol 186: 4967-4972.
Bianchi ME (2007): DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81: 1-5.
Shima H, Takatsu H, Fukuda S, et al. (2010): Identification of TOSO/FAIM3 as an Fc receptor for IgM. Int Immunol 22: 149-156.
Martin CJ, Booty MG, Rosebrock TR, et al. (2012): Efferocytosis is an innate antibacterial mechanism. Cell Host Microbe 12: 289-300.
Martin CJ, Peters KN, Behar SM (2014): Macrophages clean up: efferocytosis and microbial control. Curr Opin Microbiol 17: 17-23.
Weiss G, Schaible UE (2015): Macrophage defense mechanism against intracellular bacteria. Immunol Rev 264: 182-203.
Baumgarth N, Herman OC, Jager GC, et al. (2000): B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 192: 271-280.
Air GM (2015): Influenza virus antigenicity and broadly neutralizing epitopes. Curr Opin Virol 11: 113-121.
Boes M, Schmidt T, Linkemann K, et al. (2000): Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci USA 97: 1184-1189.
Ehrenstein MR, Cook HT, Neuberger MS (2000): Deficiency in serum immunoglobulin (Ig) M predisposes to development of IgG autoantibodies. J Exp Med 191: 1253-1258.
Boes M, Esau C, Fischer MB, et al. (1998): Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J Immunol 160: 4776-4787.
Choi SC, Wang H, Thian L, et al. (2013): Mouse IgM Fc receptor FCMR promotes B cell development and modulates antigen-driven immune response. J Immunol 190: 987-996.
Lino AC, Mohr E, Demengeot J (2013): Naturally secreted immunoglobulin limit B1 and MZ B-cell numbers throuht a microbiota-independent mechanism. Blood 122: 209-218.
Kanevets U, Sharma K, Dresser K, Shi Y (2009): A role of IgM antibodies in monosodium urate crystal formation and associated adjuvanticity. J Immunol 182: 1912-1918.
Carrero JJ, Hua X, Stenvinkel P, et al. (2009): Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis. Nephrol Dial Transplant 24: 3454-3460.
Turunen SP, Kummu O, Harila K, et al. (2012): Recognition of Porphyromonas gingivalis gingipain epitopes by natural IgM binding to malondialdehyde modified low-density lipoprotein. PLoS ONE, 7: e34910.
Feizi T (1975): Blood group antigens. Ii antigens. Proc R Soc Med 68: 799-802.
Loomes LM, Uemura K, Feizi T (1985): Interaction of Mycoplasma pneumoniae with erythrocyte glycolipids of I and i antigen types. Infect Immun 47: 15-20.
Silberstein LE, Jefferies LC, Goldman J, et al. (1991): Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood 78: 2372-2386.
Rapaka R, Ricks DM, Alcron JF, et al. (2010): Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina. J Exp Med 13: 2907-2919.
Hamanova M, Chmelikova M, Nentwich I, et al. (2015): Anti-gal IgM, IgA and IgG natural antibodies in childchood. Immunol Lett 164: 40-43.
Watts RA, Isenberg DA (1990): Autoantibodies and antibacterial antibodies: from both sides now. Ann Rheum Dis 49: 961-965.
Puga I, Cerutti A (2013): Protection by natural IgG: a sweet partnership with soluble lectins does the trick! EMBO J 32: 2897-2899.
FEATURED PRODUCTS
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe